Content Validity of Sjögren’s Syndrome Symptom Diary and Functional Assessment of Chronic Illness Therapy-Fatigue in Patients with Sjögren’s-Reference-Cited by-同舟云学术

Content Validity of Sjögren’s Syndrome Symptom Diary and Functional Assessment of Chronic Illness Therapy-Fatigue in Patients with Sjögren’s

Published:2022-09-24 Issue:6 Volume:9 Page:1559-1574
ISSN:2198-6576
Container-title:Rheumatology and Therapy
language:en
Short-container-title:Rheumatol Ther

Author:

Griffiths Natasha^ORCID,Wratten Samantha^ORCID,Flynn Jessica^ORCID,Bookman Arthur A. M.^ORCID,Ndife Briana,Hueber Wolfgang,Goswami Pushpendra^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Immunology and Allergy,Rheumatology

Link

https://link.springer.com/content/pdf/10.1007/s40744-022-00489-y.pdf

Reference49 articles.

1. Shiboski S, Shiboski C, Criswell L, et al. American College of Rheumatology classification criteria for Sjögren’s syndrome: a data-driven, expert consensus approach in the Sjögren’s International Collaborative Clinical Alliance cohort. Arthritis Care Res. 2012;64(4):475–87.

2. Patel R, Shahane A. The epidemiology of Sjögren’s syndrome. Clin Epidemiol. 2014;6:247–55.

3. Stefanski A-L, Tomiak C, Pleyer U, Dietrich T, Burmester GR, Dörner T. The diagnosis and treatment of Sjögren’s syndrome. Dtsch Arztebl Int. 2017;114(20):354.

4. Ndife B, Fenel S, Lewis S, Agashivala N. Development of a symptom diary for use in patients with Sjogren's syndrome [abstract]. Arthritis Rheumatol. 2021;73.

5. Palm Ø, Garen T, Berge Enger T, et al. Clinical pulmonary involvement in primary Sjögren’s syndrome: prevalence, quality of life and mortality—a retrospective study based on registry data. Rheumatology. 2013;52(1):173–9.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety and efficacy of subcutaneous iscalimab (CFZ533) in two distinct populations of patients with Sjögren's disease (TWINSS): week 24 results of a randomised, double-blind, placebo-controlled, phase 2b dose-ranging study;The Lancet;2024-08

2. CD40 ligand antagonist dazodalibep in Sjögren’s disease: a randomized, double-blinded, placebo-controlled, phase 2 trial;Nature Medicine;2024-06

3. Development and validation of a nomogram for predicting fatigue in patients with primary Sjögren’s syndrome;Clinical Rheumatology;2023-12-28

4. The Translation, Validation and Cultural Adaptation of Questionnaires Assessing the Quality of Life and Fatigue among Patients with Sjogren’s Syndrome for the Romanian Context;Clinics and Practice;2023-12-05

5. Qualitative Research with Patients and Physicians to Assess Content Validity and Meaningful Change on ESSDAI and ESSPRI in Sjögren’s;Rheumatology and Therapy;2022-09-16